[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2008/103183,2008,A1Locationinpatent:Page/Pagecolumn48
[1]JournalofMedicinalChemistry,2019,vol.62,p.6315-6329
1021392-83-5
150482-72-7
169750-73-6
1432681-46-3
1015937-48-0
355816-73-8
102253-71-4 | 4-(1,2,3-Thiadiazol-4-yl)pyridine | AA0006YP | MFCD00793696
102410-65-1 | Fmoc-Phg-OH | AA0007C0 | MFCD00155632
90217-02-0 | 2H-Tetrazolium, 5-cyano-2,3-bis(4-methylphenyl)-, chloride (1:1) | AA0007NV | MFCD00467521
102706-14-9 | Methyl 7-methoxy-2,2-diphenylbenzo[d][1,3]dioxole-5-carboxylate | AA000838 | MFCD00183318
113474-25-2 | Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate | AA0008LW | MFCD22741888
113732-84-6 | 2-Methyloxazole-4-carbaldehyde | AA0009E4 | MFCD03265461
114-33-0 | N-Methylnicotinamide | AA000A6O | MFCD00006384
1142190-60-0 | 3-(Trifluoromethyl)quinoxaline-2-carboxylic acid | AA000AS1 | MFCD11869266
1160247-99-3 | tert-Butyl hexahydro-1h-pyrrolo[3,2-c]pyridine-5(6h)-carboxylate | AA000BC9 | MFCD12198716
116171-03-0 | 4-Amino-5-benzoyl-2-(methylthio)thiophene-3-carbonitrile | AA000BQ1 | MFCD01860247